New #PANGO designations - BA.2.*
BA.2.4Alias of B.1.1.529.2.4, #Singapore lineage
BA.2.5Alias of B.1.1.529.2.5, lineage in #Portugal and other countries
BA.2.6Alias of B.1.1.529.2.6, lineage in #France and other countries
BA.2.7Alias of B.1.1.529.2.7, #USA lineage
These are new designations - branching from the BA.2 subvariant
more to follow ..... will update key mutational differences and transmission advantage (if any)
BA.2.4 (aka B.1.1.529.2.4) | prevalent in Singapore
Key mutation: ORF6:M58K
COV-spectrum predicts a growth advantage of 14% over BA.2 and 46% over BA.1.1 in #Singapore
BA.2 and BA.1.1 are currently the dominant lineages in circulation in Singapore
BA.2.5 (aka B.1.1.529.2.5) | prevalent in #Portugal and other countries (mostly Europe)
Key mutation: ORF1ab:P1018S
COV-spectrum predicts a global growth advantage of 2% over BA.2 and 49% over BA.1.1 in the #World
BA.2.5 (BA.2 + orf1ab:P1018S) is clearly distinct from BA.2.1 (yellow), BA.2.2 (orange), BA.2.3 (lime green)
BA.2.5 (uploaded sample - rendered in green)
BA.2.6 (aka B.1.1.529.2.6) | prevalent in #France and other countries
Key mutation: ORF3a:D27H
COV-spectrum predicts a global growth advantage of 11% over BA.2 and 62% over BA.1.1 in the #World
BA.2.7 (aka B.1.1.529.2.7) | Prevalent in #USA and other countries
Key mutation: Orf1ab:T2124I or NSP3 mutation in the group 2 marker domain
COV-spectrum predicts a global growth advantage of 13% over BA.2 and 67% over BA.1.1
Fully vaccinated individuals are better protected than the unvaccinated
Get #Boosted ASAP (especially >65 yr old; immune compromised)
Several of the current therapeutics should work - (#bebtelovimab, #paxlovid)
NPIs if you are in a hotspot
BA.2.8 (aka B.1.1.529.2.8) | Prevalent in #UnitedKingdom (#Scotland)
Key mutations: ORF3a: T9K and ORF3a: A31T
COV-spectrum predicts a global growth advantage of 34% over BA.2 and >100% over BA.1.1
#NewCoV2Lineages #Alert
Two new BA.1 lineages added to the #PANGO collection
BA.1.18 (BA.1 + ORF1a:T1822I)
BA.1.19 (BA.1 + ORF1b:L2523F)
spotted by @CorneliusRoemer
Globally both BA.1.18 & BA.1.19 are tending down
BA.1.18:cov-spectrum.org/explore/World/…
(slight increase in #France (~3%) recently)
BA.1.19: cov-spectrum.org/explore/World/…
#OmicronUpdates #NewLineageAlerts
XM - New recombinant lineage designated -BA.1.1/BA.2 #Recombinant (Prevalent in Germany, Netherlands and other countries)
Spotted by @JosetteSchoenma
more info: github.com/cov-lineages/p…
#OmicronUpdates #NewLineageAlerts
BA.2.9 alias of B.1.1.529.2.9
BA.2.10 alias of B.1.1.529.2.10
BA.2.3.1 alias of B.1.1.529.2.3.1
BA.1.17.2 B.1.1.529.1.17.2 and
XN - BA.1*/BA.2 recombinant
#Pango #Designations
BA.2.3.1 (aka B.1.1.529.2.3.1) | Prevalent in #Japan
Key mutations: Spike: Q677E
COV-spectrum predicts a growth advantage of 15% over BA.2 and 59% over BA.1.1 in Japan
Spotted by Takashi Abe | github.com/cov-lineages/p…
BA.2.9 (aka B.1.1.529.2.9) | Prevalent in #Denmark and other countries
Current Hotspots: #Poland #Germany
Key mutations: ORF3a: H78Y
COV-spectrum predicts a global growth advantage of -3% over BA.2 and 35% over BA.1.1
BA.2.9 (BA.2 + Orf3a:H78Y)
Spotted/Proposed by shay671, bitbyte2015, @JosetteSchoenma and @siamosolocani
github.com/cov-lineages/p…
BA.2.10 (aka B.1.1.529.2.10) | Prevalent in #India and other countries
Current Hotspots: #Australia #Singapore
Key mutations: ORF1b:S959P
COV-spectrum predicts a global growth advantage of -15% over BA.2 and 15% over BA.1.1
BA.2.10 (BA.2 + orf1b:S959P)
Designation proposed by @CorneliusRoemer
github.com/cov-lineages/p…
#NewCoV2Lineages #Alert
BA.2.10.1Alias of B.1.1.529.2.10.1, Prevalent in #Singapore and other countries
BA.2.3.2Alias of B.1.1.529.2.3.2, Prevalent in #Vietnam and #Japan
Summary of PANGO designations: pango.network/summary-of-des…
BA.2.3.2 (aka B.1.1.529.2.3.2) | Prevalent in #Vietnam #Japan and other countries
Key mutations: E:S55F
COV-spectrum predicts a global growth advantage of 12% over BA.2 and 64% over BA.1.1
#PANGO designations: pango.network/summary-of-des…
BA.2.10.1 (aka B.1.1.529.2.10.1) | Prevalent in #Singapore and other countries
Key mutations: S:G798D
COV-spectrum predicts a growth advantage of 11% over BA.2 and 43% over BA.1.1 in Singapore
#PANGO designations: pango.network/summary-of-des…
#OmicronUpdates #NewLineageAlerts
BA.4 alias of BA.1.1.529.4
BA.5 alias of BA.1.1.529.5
BA.2.11 alias of BA.1.1.529.2.11
BA.2.12 alias of BA.1.1.529.2.12
BA.2.12.1 alias of BA.1.1.529.2.12.1
#Pango #Designations
These are new #PANGO designations - BA.4 & BA.5 have key signature mutations that warrants a good closer look...
BA.2.11, BA.2.12 & BA.2.12.1 are branching from the BA.2 subvariant
more to follow ..... will update key mutational differences and transmission advantage (if any)
BA.2.11 (aka B.1.1.529.2.11) | Prevalent in #France
Key mutations: ORF1a:S2519P+S:L452R
COV-spectrum predicts a global growth advantage of 55% over BA.2 and 149% over BA.1.1 (sample size is low - these numbers are not reliable yet)
Spotted by vthibault35
#PANGO issue: #491
BA.2.12 (aka B.1.1.529.2.12) | Prevalent in #NorthAmerica, #Europe
Key mutations: Spike S704L
COV-spectrum predicts a global growth advantage of 3% over BA.2 and 47% over BA.1.1
Mutation spotted by
@nzm8qs, @CorneliusRoemer and others
#PANGO issue: #499
BA.2.12.1 (aka B.1.1.529.2.12.1) | Prevalent in #UnitedStates
Key mutations: Spike S704L, L452Q
COV-spectrum predicts a global growth advantage of 32% over BA.2 and 105% over BA.1.1
Mutation spotted by @nzm8qs and others
#PANGO issue: #499
BA.5 (aka B.1.1.529.5) | Prevalent in #SouthAfrica
Key mutations: Spike L452R, F486V, 493Q-reversion; M:D3N
COV-spectrum predicts a significant growth advantage over BA.1*/2* (sample size is low - these numbers are not reliable yet)
#PANGO issue: github.com/cov-lineages/p…
BA.4 (aka B.1.1.529.4) | Prevalent in #SouthAfrica
Key mutations: Spike L452R, F486V, 493Q-reversion; N:P151S
COV-spectrum predicts a significant growth advantage over BA.1*/2* (sample size is low - these numbers are not reliable yet)
#PANGO issue: github.com/cov-lineages/p…
Test positivity in #SouthAfrica is 5.8%
No significant increase in Hospitalizations or deaths
nicd.ac.za/diseases-a-z-i…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.